HIV: Cell Binding and Entry

HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor

Feng, Y. Y., Broder, C. C., Kennedy, P. E., & Berger, E. A. (1996) · Science · doi:10.1126/science.272.5263.872 · Cited by 4,169

Identification of a major co-receptor for primary isolates of HIV-1

Deng, H., Liu, R., Ellmeier, W., Choe, S. S., Unutmaz, D., Burkhart, M. D., Marzio, P. D., Marmon, S., Sutton, R. E., Hill, C. M., et al. (1996) · Nature · doi:10.1038/381661a0 · Cited by 3,640

HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5

Dragic, T., Litwin, V., Allaway, G. P., Martin, S. R., Huang, Y., Nagashima, K. A., Cayanan, C. S., Maddon, P. J., Koup, R. A., Moore, J. P., et al. (1996) · Nature · doi:10.1038/381667a0 · Cited by 3,173

Homozygous Defect in HIV-1 Coreceptor Accounts for Resistance of Some Multiply-Exposed Individuals to HIV-1 Infection

Liu, R., Paxton, W. A., Choe, S., Ceradini, D., Martin, S. R., Horuk, R., MacDonald, M. E., Stuhlmann, H., Koup, R. A., & Landau, N. R. (1996) · Cell · doi:10.1016/s0092-8674(00)80110-5 · Cited by 3,074

Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody

Kwong, P. D., Wyatt, R. T., Robinson, J. E., Sweet, R. W., Sodroski, J., & Hendrickson, W. A. (1998) · Nature · doi:10.1038/31405 · Cited by 2,963

Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene

Samson, M., Libert, F., Doranz, B. J., Rucker, J. B., Liesnard, C., Farber, C., Saragosti, S., Lapouméroulie, C., Cognaux, J., Forceille, C., et al. (1996) · Nature · doi:10.1038/382722a0 · Cited by 2,885

Identification of RANTES, MIP-1α, and MIP-1β as the Major HIV-Suppressive Factors Produced by CD8 + T Cells

Cocchi, F., DeVico, A. L., Demo, A. G., Arya, S. K., Gallo, R. C., & Lusso, P. (1995) · Science · doi:10.1126/science.270.5243.1811 · Cited by 2,867

Pneumocystis cariniiPneumonia and Mucosal Candidiasis in Previously Healthy Homosexual Men

Gottlieb, M. S., Schroff, R. W., Schanker, H. M., Weisman, J. D., Fan, P. T., Wolf, R. A., & Saxon, A. (1981) · New England Journal of Medicine · doi:10.1056/nejm198112103052401 · Cited by 2,723

CC CKR5: A RANTES, MIP-1α, MIP-1β Receptor as a Fusion Cofactor for Macrophage-Tropic HIV-1

Alkhatib, G., Combadière, C., Broder, C. C., Feng, Y., Kennedy, P. E., Murphy, P. M., & Berger, E. A. (1996) · Science · doi:10.1126/science.272.5270.1955 · Cited by 2,703

Genetic Restriction of HIV-1 Infection and Progression to AIDS by a Deletion Allele of the CKR5 Structural Gene

Dean, M. C., Carrington, M. N., Winkler, C. A., Huttley, G. A., Smith, M. W., Allikmets, R. L., Goedert, J. J., Buchbinder, S., Vittinghoff, E., Gomperts, E. D., et al. (1996) · Science · doi:10.1126/science.273.5283.1856 · Cited by 2,503

Mathematical model for force and energy of virion-cell interactions during full engulfment in HIV: Impact of virion maturation and host cell morphology

Kruse, E., Abdalrahman, T., Selhorst, P., & Franz, T. (2023) · Biomechanics and Modeling in Mechanobiology · doi:10.1007/s10237-023-01736-z · Cited by 3

Zinc C293 as a novel scaffold with dual activity against HIV-1 integrase and reverse transcriptase

Sayyed, S. K., Quraishi, M., Rajasekharan, S. K., Sonawane, T., & Ravichandran, V. (2025) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2025.108573 · Cited by 3

Tryptophan-Aspartic Acid-Containing Peptide Analog from Coronin 1 Inhibits Model Membrane Fusion and Enveloped Viral Infection in Cells

Pandia, S., Qazi, B., Vishwakarma, V., Gautam, S., Meshram, C. D., Chakraborty, H., & Haldar, S. (2025) · Langmuir · doi:10.1021/acs.langmuir.5c03627 · Cited by 3

Keeping your armour intact: How HIV‐1 evades detection by the innate immune system

Maelfait, J., Seiradake, E., & Rehwinkel, J. (2014) · BioEssays · doi:10.1002/bies.201400019 · Cited by 3

Novel Bent Conformation of CD4 Induced by HIV-1 Inhibitor Indirectly Prevents Productive Viral Attachment

Wensel, D. L., Williams, S. P., Dixon, D. P., Ward, P., McCormick, P., Concha, N. O., Stewart, E. L., Hong, X., Mazzucco, C. E., Pal, S., et al. (2021) · Journal of Molecular Biology · doi:10.1016/j.jmb.2021.167395 · Cited by 3

A search for potential anti-HIV phytoconstituents from the natural product repository

Pathak, D. V., Sagar, S. R., Bhatt, H., & Patel, P. K. (2022) · Oriental Pharmacy and Experimental Medicine · doi:10.1007/s13596-022-00646-2 · Cited by 3

Role of nanocarriers for the effective delivery of anti-HIV drugs

Kharwade, R., & Mahajan, N. M. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-89839-3.00011-7 · Cited by 3

Retinoids: novel potential therapeutics in the pursuit of HIV-1 cure

Purssell, A., McGuinty, M., Vulesevic, B., & Angel, J. B. (2022) · Frontiers in Virology · doi:10.3389/fviro.2022.957124 · Cited by 3

HIV and SARS-CoV-2 Co-Infection: From Population Study Evidence to In Vitro Studies

Stefani, C., Fantoni, T., Bissoli, M., Thomas, J., & Ruggiero, A. (2022) · Life · doi:10.3390/life12122089 · Cited by 2

Structural and Functional Characterization of Indane-Core CD4-Mimetic Compounds Substituted with Heterocyclic Amines

Chaplain, C., Fritschi, C. J., Anang, S., Gong, Z. L., Richard, J., Bourassa, C., Liang, S., Mohammadi, M., Park, J., Finzi, A., et al. (2022) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.2c00376 · Cited by 3

CXCR4 Recognition by L- and D-Peptides Containing the Full-Length V3 Loop of HIV-1 gp120

Zhu, R., Sang, X., Zhou, J., Meng, Q., Huang, L., Xu, Y., An, J., & Huang, Z. (2023) · Viruses · doi:10.3390/v15051084 · Cited by 3

Spastin is required for human immunodeficiency virus-1 efficient replication through cooperation with the endosomal sorting complex required for transport (ESCRT) protein

Shen, W., Liu, C., Hu, Y., Ding, Q., Feng, J., Liu, Z., & Kong, X. (2023) · Virologica Sinica · doi:10.1016/j.virs.2023.05.006 · Cited by 3

Killing two birds with one stone: CRISPR/Cas9 CCR5 knockout hematopoietic stem cells transplantation to treat patients with HIV infection and hematological malignancies concurrently

Au, T. Y., Arudkumar, J., Assavarittirong, C., & Benjamin, S. (2023) · Clinical and Experimental Medicine · doi:10.1007/s10238-023-01129-7 · Cited by 3

Female Genital Tract Host Factors and Tenofovir and Lamivudine Active Metabolites

Lantz, A. M., Kiweewa, F. M., Johnson, R., Isingel, E., Nakalega, R., Kabwigu, S., Beksinska, M. E., & Nicol, M. R. (2024) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiae372 · Cited by 3

CD300LF Polymorphisms of Inbred Mouse Strains Confer Resistance to Murine Norovirus Infection in a Cell Type-Dependent Manner

Furlong, K., Biering, S. B., Choi, J., Wilen, C. B., Orchard, R. C., Wobus, C. E., Nelson, C. A., Fremont, D. H., Baldridge, M. T., Randall, G. C., et al. (2020) · Journal of Virology · doi:10.1128/jvi.00837-20 · Cited by 3

Modulation of Cell Surface Receptor Expression by Modified Vaccinia Virus Ankara in Leukocytes of Healthy and HIV-Infected Individuals

Pereira, A. L., Jouhault, Q., López, E. M., Cosma, A., Lambotte, O., Grand, R. L., Lehmann, M. H., & Tchitchek, N. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.02096 · Cited by 3

Roles of variable linker length in dual acting virucidal entry inhibitors on HIV ‐1 potency via on‐the‐fly free energy molecular simulations

Gossert, S. T., Parajuli, B., CHAIKEN, I. M., & Abrams, C. F. (2020) · Protein Science · doi:10.1002/pro.3949 · Cited by 3

Brief Report: HIV-1 Seroconversion Is Not Associated With Prolonged Rectal Mucosal Inflammation

Blair, C. S., Lake, J. E., Passaro, R. C., Chávez-Gomez, S., Segura, E. R., Elliott, J. E., Fulcher, J. A., SHOPTAW, S. J., Cabello, R. L., & Clark, J. L. (2020) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000002601 · Cited by 3

Various strategies for developing APOBEC3G protectors to circumvent human immunodeficiency virus type 1

Bao, Q., & Zhou, J. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.115188 · Cited by 4

New Antiretrovirals for HIV and Antivirals for HBV

Lazerwith, S. E., Siegel, D. S., McFadden, R. M., Mish, M., & Tse, W. C. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-409547-2.12407-2 · Cited by 4

Chemical and Biophysical Approaches for Complete Characterization of Lectin–Carbohydrate Interactions

Lusvarghi, S., Ghirlando, R., Davison, J. R., & Bewley, C. A. (2017) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2017.06.010 · Cited by 3

Governed by surface amino acid composition: HIV capsid passage through the NPC barrierPreprint

Fu, L., Cheng, S., Riedel, D., Kopecny, L., Schuh, M., & Görlich, D. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.03.13.643050 · Cited by 3

Exploration of marine macro algal-derived compounds as antiviral drugs: A review on the types, mechanisms of action, and challenges

Dinakarkumar, Y., Ramakrishnan, G., Ramaiah, M. J., Reddy, M. M., John, R. M., Raj, A. L. T., & Chamarthy, S. (2025) · Pharmacological Research - Natural Products · doi:10.1016/j.prenap.2025.100215 · Cited by 2

Molecular Docking Studies of Scutellaria baicalensis Targeting HIV Co-Receptor CXCR4

Mohamed Akram Ali, S., MF, T. A. K., Helina, N., Rajamohamed, H., Shobana, A., & Kumar, S. V. (2025) · Current HIV Research · doi:10.2174/011570162x345178250316123743 · Cited by 2

Antiviral Bioactive Compounds: Their Activities and Underlying Mechanisms Against Human Viral Infections

Ghosh, S., Jana, K., Parua, P., Seth, A., Bishal, A., Debnath, B., Rout, S. K., Halder, J., Rai, V. K., Dash, P., et al. (2025) · Recent Advances in Anti-Infective Drug Discovery · doi:10.2174/0127724344376918250328054623 · Cited by 2

Pannexin-1 channels, extracellular ATP, and purinergic receptors are essential for CCR5/CXCR4 clustering and HIV entry

Ajasin, D., Velasquez, S., Gibson, J. E., Scemes, E., Cibelli, A., Spray, D. C., & Eugenín, E. A. (2025) · NeuroImmune Pharmacology and Therapeutics · doi:10.1515/nipt-2025-0005 · Cited by 2

Unleashing the Antiviral Potential of Stapled Peptides: A New Frontier in Combating Human Neurotropic Viral Infections

Patil, S., Rahangdale, R. R., Pasupuleti, M., Santhoshkumar, P., & Hariharapura, R. C. (2025) · Microbial Biotechnology · doi:10.1111/1751-7915.70221 · Cited by 2

HIV-1 signalling remodels nuclear pores to licence infection

Mesner, D., Whelan, M. V. X., Shivkumar, M., Reuschl, A., Chiozzi, R. Z., Thalassinos, K., de Bruin, R. A. M., & Jolly, C. L. (2026) · Nature · doi:10.1038/s41586-026-10453-3 · Cited by 2

Human Immunodeficiency Virus Type-1

Spector, S. A. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.00088-x · Cited by 2

Structural Insights from HIV-Antibody Coevolution and Related Immunization Studies

Zhou, J. O., Ton, T., Morriss, J. W., Nguyen, D. N., & Fera, D. (2018) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2018.0097 · Cited by 2

Aquatic Animals Operating at High Reynolds Numbers

Fish, F. E. (2020) · Cambridge University Press eBooks · doi:10.1017/9781139058995.011 · Cited by 2

Immunotherapy with Cell-Based Biological Drugs to Cure HIV-1 Infection

Siracusano, G., & Lopalco, L. (2021) · Cells · doi:10.3390/cells11010077 · Cited by 2

Identification of peptide epitopes of the gp120 protein of HIV-1 capable of inducing cellular and humoral immunity

García‐Machorro, J., Gutiérrez‐Sánchez, M., Rojas-Ortega, D. A., Bello, M., Andrade-Ochoa, S., Díaz-Hernández, S., Correa‐Basurto, J., & Hernández, S. R. (2023) · RSC Advances · doi:10.1039/d2ra08160a · Cited by 2

Three prime repair exonuclease 1 preferentially degrades the integration-incompetent HIV-1 DNA through favorable kinetics, thermodynamic, structural, and conformational properties

Prakash, P., Khodke, P., Balasubramaniam, M., Davids, B.-O., Hollis, T., Davis, J. S., Pandhare, J., Kumbhar, B. V., & Dash, C. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.107438 · Cited by 2

New 3-[(tetrazol-5-yl)methine-N-benzylamine)]-1H-indole derivatives: Synthesis, anti-HIV activity and molecular docking studies

Ragedi, M. T. C., Naidu, D., Oyeneyin, O. E., Mkhwanazi, N. P., & Tukulula, M. (2025) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2025.118301 · Cited by 3

Modulation of transferrin receptor by HIV-2

Al-Muffti, A. S., Kiarie, I. W., Tőzsér, J., & Mahdi, M. (2025) · Virology Journal · doi:10.1186/s12985-025-02987-1 · Cited by 2

Viral Envelope Is a Major Determinant of Enhanced Fitness of a Multidrug-Resistant HIV-1 Variant

Mohri, H., Prada, N., & Markowitz, M. H. (2015) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000000524 · Cited by 2

Single-amino acid mutation 66SR in Gag-matrix enhances viral single-cycle infectivity of R5-tropic HIV-1rmt

Doi, N., Sakai, Y., Miyazaki, Y., Adachi, A., & Nomaguchi, M. (2015) · The Journal of Medical Investigation · doi:10.2152/jmi.62.228 · Cited by 2

A Conserved Glycan in the C2 Domain of HIV-1 Envelope Acts as a Molecular Switch to Control X4 Utilization by Clonal Variants with Identical V3 Loops

Lombardi, F., Nakamura, K. J., Chen, T., Sobrera, E. R., Tobin, N. H., & Aldrovandi, G. M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0128116 · Cited by 2

Cervical Cancer in Human Immunodeficiency Virus (HIV) Positive Patients

Ntekim, A. (2016) · InTech eBooks · doi:10.5772/60664 · Cited by 2

HIV/acquired immunodeficiency syndrome

Vermund, S. H., & Solomon, S. (2015) · doi:10.1093/med/9780199661756.003.0213 · Cited by 2

Retroviral restriction: nature's own solution

Jones, C. E., & McKnight, Á. (2016) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000322 · Cited by 3

Challenges and limitations in the studies of glycoproteins: A computational chemist's perspective

Balli, O. I., Uversky, V. N., Durdağı, S., & Coskuner‐Weber, O. (2021) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.26242 · Cited by 2

Review : Imunoterapi Penanganan Infeksi Virus

Usmar, U., Fitri, A. M. N., Yuliana, D., & Nainu, F. (2021) · Jurnal Mandala Pharmacon Indonesia · doi:10.35311/jmpi.v7i1.76 · Cited by 2

Nano-targeted drug delivery approaches for viral infections

Gebrecherkos, T., Dejene, T. A., Barabadi, H., Mostafavi, E., & Saravanan, M. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-90792-7.00015-4 · Cited by 2

Accounting for multi-delay effects in an HIV-1 infection model with saturated infection rate, recovery and proliferation of host cells

Adak, D., Bairagi, N., & Hakl, R. (2020) · BIOMATH · doi:10.11145/j.biomath.2020.12.297 · Cited by 2

CRISPR in HIV: Dangers of CCR5 Deletion

Rusconi, S., & Giacomelli, A. (2020) · Future Virology · doi:10.2217/fvl-2020-0039 · Cited by 2

Anti-retroviral therapy and serum protein levels in HIV-1 seropositive patients: a five-year retrospective studyPreprint

Akor, S. E., Haruna, M., Eneojo-Abah, G., Yisa, B. N., Titus, E. F., Musa, D. A., Oguche, J., Shaibu, S., Salami, T., Bukbuk, D. N., et al. (2020) · medRxiv · doi:10.1101/2020.06.23.20129338 · Cited by 2

HIV Biology: Detailed Insight into Virion Structural Organization and Its Pathogenesis

Agrawal, D., Chand, K., Preethi, L., Bhukya, P. L., & Barman, M. K. (2024) · Springer eBooks · doi:10.1007/978-981-97-4480-0_22 · Cited by 1

Optimization of a lentivirus-mediated gene therapy targeting HIV-1 RNA to eliminate HIV-1-infected cells

Buckingham, A. B., Ho, S., Knops-Mckim, F., Ingemarsdotter, C. K., & Lever, A. M. L. (2024) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2024.102341 · Cited by 1

Engineering hematopoietic stem and progenitor cells to generate red blood cells as viral traps against HIV-1

Luna, S. E., Feist, W. N., Ben-Efraim, K., Pendergast, M. A., Ekman, F. K., Hernandez, B. N., Merritt-Garza, M. E., Romero, K., Kostamo, Z., Amorin, N. A., et al. (2026) · Molecular Therapy Advances · doi:10.1016/j.omta.2026.201799 · Cited by 1

Immunoinformatic Prediction of HIV-1 Glycoprotein gp120 and Nef Epitopes Conjugated to HBsAg-Binding Protein (SBP) to Induce the Humoral and Cellular Immune Response

Habib, A., Xu, X., Xie, J., & Zhu, N. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26199828 · Cited by 2

Discovery of a Potent Tat-Binding Antiretroviral Compound Using a Two-Step Screening Approach

Shin, Y., Jung, Y., Kim, D., Gim, J., Bae, S., Yoon, C., Park, C. M., & Kim, H. G. (2025) · Biochemistry · doi:10.1021/acs.biochem.5c00203 · Cited by 1

Clinical trial results provide the rationale to protect dual HIV-specific T cells with a signaling-defective HIV fusion inhibitor

Tebas, P., Jadlowsky, J. K., Zhou, Y., Pampena, M. B., Leslie, G. J., Liu, N., Srivatsa, S., Maldini, C. R., Wang, J., Tsang, C. J., et al. (2026) · Molecular Therapy · doi:10.1016/j.ymthe.2026.01.006 · Cited by 1

Variations and evolution of HIV-1 provirus in peripheral blood under the pressure of ART

Liang, Y., Deng, H., Li, Q., Zhang, C., Li, J., Kong, Q., Zou, Z., Li, L., & 陈伟烈 (2026) · Virus Evolution · doi:10.1093/ve/veag019 · Cited by 1

Basic Virology

Veenstra, T. D. (2026) · Advances in experimental medicine and biology · doi:10.1007/978-3-032-22340-1_2 · Cited by 1

Deadbolt Drug Discovery: Locking the Door to Class 1 Viral Entry by Small Molecules

Sloan, J. P., Rong, L., & Moore, T. W. (2026) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.6c00302 · Cited by 1

Targeting Chemokine Receptors for HIV: Past, Present and Future

Fricker, S. P. (2015) · Future Medicinal Chemistry · doi:10.4155/fmc.15.153 · Cited by 1

HIV-1 Biology at the Protein Level

Ott, D. E. (2016) · Springer eBooks · doi:10.1007/978-1-4939-6542-7_2 · Cited by 1

Human Immunodeficiency Viruses and Human T-lymphotropic Viruses

Schüpbach, J. (2016) · ASM Press eBooks · doi:10.1128/9781555819156.ch37 · Cited by 1

HIV-1 Capsid as a Target for Antiviral Therapy

Zhang, Z., & Zhang, F. (2016) · Journal of AIDS & Clinical Research · doi:10.4172/2155-6113.1000536 · Cited by 1

Role of CD4 Receptor in Diagnosis of AIDS

Tn, D. (2017) · Journal of Family Medicine · doi:10.26420/jfammed.2017.1105 · Cited by 1

Coreceptor Tropism and Maraviroc Sensitivity of Clonally Derived Ethiopian HIV-1C Strains Using an in-house Phenotypic Assay and Commonly Used Genotypic Methods

Kalu, A. W., Telele, N. F., Aralaguppe, S. G., Gebre-Selassie, S., Fekade, D., Marrone, G., & Sönnerborg, A. B. (2018) · Current HIV Research · doi:10.2174/1570162x16666180515124836 · Cited by 1

Development of Potential HIV-1 Inhibitors by In Silico Click Chemistry And Molecular Modeling Methods

Andrianov, A. M., Nikolaev, G. I., Kashyn, I. A., & Tuzikov, A. V. (2018) · Mathematical Biology and Bioinformatics · doi:10.17537/2018.13.507 · Cited by 1

Krankheiten des immunologischen Gedächtnisses

Straub, R. H. (2019) · Springer eBooks · doi:10.1007/978-3-662-59131-4_11 · Cited by 1

Replication

Cann, A. J. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-801946-7.00004-3 · Cited by 1

Biological Activities of Lasso Peptides and Structure–Activity Relationships

Li, Y., Zirah, S., & Rebuffat, S. (2014) · SpringerBriefs in microbiology · doi:10.1007/978-1-4939-1010-6_3 · Cited by 1

Viroinformatics study: polytope mapping of envelope glycoprotein to tackle HIV-2 infection and develop vaccine candidate

Kharisma, V. D., Widyananda, M. H., Probojati, R. T., Ansori, A. N. M., Murtadlo, A. A. A., Tamam, M. B., Wicaksono, A., & Turista, D. D. R. (2021) · Genbinesia Journal of Biology · doi:10.55655/genbinesia.v1i1.6 · Cited by 1

Nanotechnological strategies for drug delivery and treatment of COVID-19

Ingle, A. P., Gade, A., Bonde, S., Wypij, M., Golińska, P., & Rai, M. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-91763-6.00013-8 · Cited by 1

Human Immunodeficiency Virus I: History, Epidemiology, Transmission, and Pathogenesis

Multani, A., Becken, B., Padival, S., & Cunningham, C. K. (2025) · Springer eBooks · doi:10.1007/978-3-031-84089-0_58 · Cited by 1

Mycobacterium tuberculosis and HIV coinfection : Effects on innate immunity and strategies to boost the immune response

Andersson, A.-M. (2019) · Linköping University medical dissertations · doi:10.3384/diss.diva-154605 · Cited by 1

RME-based pharmacology: The inhibition of viral entry as therapeutic perspective in viral diseases including AIDS. Hypothesis updated and enlarged

Chaldakov, G. N., & Yanev, S. G. (2018) · Biomedical Reviews · doi:10.14748/bmr.v29.5856 · Cited by 1

Designing Nature-Inspired Liquid-Repellent Surfaces

Stogin, B. B., Wang, L., & Wong, T. (2020) · Cambridge University Press eBooks · doi:10.1017/9781139058995.013 · Cited by 1

Bioinspired and Biomimetic Design of Multilayered and Multiscale Structures

Salifu, A. A., Mannoor, M. S., & Soboyejo, W. O. (2020) · Cambridge University Press eBooks · doi:10.1017/9781139058995.002 · Cited by 1

Viral Phenotypic Resistance Assays

Reeves, J. D., & Parkin, N. T. (2017) · Springer eBooks · doi:10.1007/978-3-319-47266-9_35 · Cited by 1

Bionic Organs

Kiaee, K., Jodat, Y. A., & Mannoor, M. S. (2020) · Cambridge University Press eBooks · doi:10.1017/9781139058995.008 · Cited by 1

Ubiquitination and SUMOylation in HIV Infection: Friends and Foes

Colomer-Lluch, M., Castro‐Gonzalez, S., & Serra-Moreno, R. (2019) · Caister Academic Press eBooks · doi:10.21775/9781912530120.24 · Cited by 1

Post-transcriptional regulation of HIV-1 gene expression

Tripathi, A., Mitra, A., Dasgupta, A., & Mitra, D. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-91305-8.00004-1 · Cited by 1

HIV-1 coreceptor CCR5: gene characterization and expression

Picton, A. C. P. (2014) · University of the Witwatersrand, Johannesburg Institutional Repository on DSpace (University of the Witwatersrand, Johannesburg) · Cited by 1

Erythrocyte apoptosis (erythroptosis) and anaemia in chronic HIV-1 infection: relationship with immune activation and viraemia

Loots, S. (2013) · SUNScholar (Stellenbosch University) · Cited by 1

Development of Tenofovir Prodrugs as Rectal Microbicides for HIV Prevention

Lyu, Y. (2016) · D-Scholarship@Pitt (University of Pittsburgh) · Cited by 1

Vesiculovirus G protein-based stable cell lines for continuous lentiviral vector production

Tijani, M. (2018) · UCL Discovery (University College London) · Cited by 1

A tyrosine-based trafficking signal in the simian immunodeficiency virus envelope cytoplasmic domain is strongly selected for in pathogenic SIV infectionPreprint

Lawrence, S. P., Elser, S. E., Torben, W., Blair, R. V., Pahar, B., Aye, P. P., Schiro, F. R., Szeltner, D. M., Doyle‐Meyers, L. A., Haggarty, B., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.03.31.437834 · Cited by 1

Multiple Treatment Interruptions and Protecting HIV-Specific CD4 T-Cells Enables Durable CTL Response and Viral ControlPreprint

Jain, A., Cánepa, G. E., Liou, M.-L., Fledderman, E. L., Chapoval, A. I., Xiao, L., Mukherjee, I., Galvin, J. A., Kumar, P. N., Bordón, J., et al. (2023) · medRxiv · doi:10.1101/2023.10.24.23297421 · Cited by 1

Phenotypic Characteristics of Mucosally Transmitted HIV-1

Parrish, N. F. (2013) · ScholarlyCommons (University of Pennsylvania)

Caracterização molecular da gp120 do HIV-1 e suas implicações sobre o tropismo pelos correceptores CCR5 e CXCR4

Arruda, L. B. (2014) · doi:10.11606/t.99.2014.tde-07072014-115528

High-Throughput Screening to Discover Host Factors Involved in Filoviral Entry

O’Hearn, A. E. (2012) · Figshare

Identifying and characterizing the degradative pathway of the retroviral restriction factor rhTRIM5alpha

Nelson, R. S. (2013)

Qual o papel das células natural killer na infeção por VIH-SIDA

Correia, R. N. (2013) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)

HIV-1 vaccine epitope delivery based on foamy viral hybrid proteins and vectors

Muhle, M. E. (2015) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.25646/5339

NEUROTROPHIN-CHEMOKINE RECEPTOR INTERACTIONS ON MACROPHAGES REGULATE HIV NEUROPATHOGENESIS

Williams, K. S. (2015) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/3af8-4p67

Amino acid predictors of HIV-1 coreceptor use in different subtypes and their application to antiretroviral treatment

Pramanik, L. (2014) · Figshare

Sialic acid-binding Ig-like lectin-7 interacts with HIV-1 gp120 and facilitates infection of CD4 pos

Varchetta, S., Lusso, P., Hudspeth, K. L., Mikulak, J., Mele, D., Paolucci, S., Cimbro, R., Malnati, M., Maserati, R., Mondelli, M. U., et al. (2013)

Genotypic Detection of Resistance to Antiretroviral Therapy (Art): A Brief Review

Ga, M. (2014)

Establishment and evaluation of a feline foamy virus subviral particle-based vaccine strategy for induction of neutralizing antibodies against HIV-1

Schneikart, G. (2014) · Publication server of the Robert Koch Institute (Robert Kock Institute) · doi:10.25646/5347

Drug Resistance Mutations in Human Immunodeficiency Virus Type 2 Strains from Patients in Two Treatment Centers in Ghana

Abana, C. Z.-Y. (2015)

HIV-1-induced cell-cell fusion: Host regulation and consequences for viral spread

Symeonides, M. (2016) · ScholarWorks -A service of University of Vermont Libraries (University of Vermont)

Generation of Human Immunodeficiency Type 1 Escape Mutants to Peptide Triazole Entry-Inhibiting Virus Inactivators

Holmes, A. P. (2016)

Computer-Based Technologies for Virtual Screening and Analysis of Chemical Compounds Promising for Anti-HIV-1 Drug Design

Andrianov, A. M., Kashyn, I. A., & Tuzikov, A. V. (2017) · Communications in computer and information science · doi:10.1007/978-3-319-54220-1_2

Directed Evolution of gp120 Binding Mutants of the Lectin Cyanovirin-N

Ruben, M. A. (2013)

Molecular Mechanisms of HIV Entry

Wilen, C. B., Tilton, J. C., & Doms, R. W. (2011) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-0980-9_10 · Cited by 215

Membrane organization of virus and target cell plays a role in HIV entry

Dumas, F., Preira, P., & Salomé, L. (2014) · Biochimie · doi:10.1016/j.biochi.2014.08.015 · Cited by 18

Mechanisms and Specificity of HIV Entry into Host Cells

Düzgüneş, N. (1991) · Advances in experimental medicine and biology · doi:10.1007/978-1-4684-5976-0 · Cited by 8

Cell surface receptors, virus entry and tropism of primate lentiviruses

Clapham, P. R., & McKnight, Á. (2002) · Journal of General Virology · doi:10.1099/0022-1317-83-8-1809 · Cited by 255

HIV entry: a game of hide-and-fuse?

Melikyan, G. B. (2013) · Current Opinion in Virology · doi:10.1016/j.coviro.2013.09.004 · Cited by 128